US Stock MarketDetailed Quotes

EPIX ESSA Pharma

Watchlist
  • 1.700
  • +0.010+0.59%
Close Feb 26 16:00 ET
75.46MMarket Cap-2.46P/E (TTM)

About ESSA Pharma Company

ESSA Pharma, Inc. is a clinical stage pharmaceutical company. It engages in the business of developing small molecule drugs for the treatment of prostate cancer. The company was founded by Marianne D. Sadar and Raymond J. Andersen on January 6, 2009 and is headquartered in Vancouver, Canada.

Company Profile

SymbolEPIX
Company NameESSA Pharma
Listing DateJul 9, 2015
Founded2009
CEODr. David Ross Parkinson, M.D.
MarketNASDAQ
Employees35
Fiscal Year Ends09-30
Address999 West Broadway,Suite 720
CityVancouver
ProvinceBritish Columbia
CountryCanada
Zip CodeV5Z 1K5
Phone1-778-331-0962
Websitehttp://www.essapharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. David Ross Parkinson, M.D.
  • Director, President and Chief Executive Officer
  • 4.06M
  • Peter Virsik
  • Executive Vice President and Chief Operating Officer
  • 1.69M
  • David Wood
  • Chief Financial Officer and Principal Accounting Officer
  • 1.66M
  • Dr. Alessandra Cesano, M.D.
  • Vice President and Chief Medical Officer
  • 2.49M
  • Dr. Richard M. Glickman,L.L.D.
  • Chairman of the Board
  • 707.64K
  • Sanford S. Zweifach
  • Independent Director
  • 502.39K
  • Marella Thorell
  • Independent Director
  • 502.14K
  • Lauren Merendino
  • Independent Director
  • 265.44K
  • Scott Requadt
  • Independent Director
  • 501.39K
  • John Alexander Martin
  • Independent Director
  • 492.39K
  • Gary Sollis
  • Independent Director
  • 504.39K
  • Dr. Philip Kantoff, M.D.
  • Independent Director
  • 489.39K
  • Franklin M. Berger, C.F.A.
  • Independent Director
  • 504.39K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Strategy
MSTR
+5.09%
Meta Platforms
META
+2.46%
Oracle
ORCL
+2.33%
Amazon
AMZN
+0.73%
Salesforce
CRM
+0.47%

Unlock the Full List